Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with...

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Genome-wide association studies (GWAS) have identified common variants associated with esophageal squamous cell carcinoma (ESCC) risk.
• However, these common variants do not fully explain the heritability of ESCC, suggesting a role for other genetic factors.

Discussion:

• This exome-wide study investigated low-frequency susceptibility loci in a large cohort of ESCC patients and controls.
• Six novel susceptibility loci (CCHCR1, TCN2, TNXB, LTA, CYP26B1, FASN) were identified, with some low-frequency variants exhibiting a significant effect size (odds ratio > 1.5).
• A specific variant in CYP26B1 was associated with lower serum all-trans retinoic acid levels, potentially due to enhanced catabolism, impacting this anticancer nutrient.

Key Insights:

• Identification of six new susceptibility loci for ESCC, expanding the known genetic architecture of the disease.
• Discovery of low-frequency variants with substantial impact on ESCC risk, contributing to the unexplained heritability.
• Elucidation of a potential mechanism involving CYP26B1 and all-trans retinoic acid metabolism in ESCC pathogenesis.

Outlook:

• These findings underscore the importance of rare and low-frequency coding variants in the development of ESCC.
• Further research into these novel loci and their functional consequences may reveal new therapeutic targets.
• Integrating genetic findings with metabolic pathways offers a more comprehensive understanding of ESCC etiology.